|
|
Blood, 1 December 2005, Vol. 106, No. 12, pp. 3831-3838.
Prepublished online as a Blood First Edition Paper on August 25, 2005; DOI 10.1182/blood-2005-03-0889.
Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Inhibition of pathologic retinal neovascularization by -defensins
Matina Economopoulou,
Khalil Bdeir,
Douglas B. Cines,
Franz Fogt,
Yasmina Bdeir,
Jacek Lubkowski,
Wuyuan Lu,
Klaus T. Preissner,
Hans-Peter Hammes, and
Triantafyllos Chavakis
From the Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD; Department of Internal Medicine V, University Clinic Mannheim, Germany; Department of Ophthalmology, Justus-Liebig-University, Giessen, Germany; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA; Macromolecular Assembly Structure and Cell Signaling Section, National Cancer Institute, Frederick, MD; Institute of Human Virology, University of Maryland Biotechnology Institute, Baltimore, MD; and Institute for Biochemistry, Justus-Liebig-University, Giessen, Germany.
Proliferative retinopathies, such as those complicating prematurity and diabetes, are major causes of blindness. A prominent feature of these retinopathies is excessive neovascularization, which is orchestrated by the hypoxia-induced vascular endothelial growth factor (VEGF) stimulating endothelial cells and the integrin-mediated adhesive interactions of endothelial cells with extracellular matrix components such as fibronectin (FN). Recently, we demonstrated that -defensins interfere with 5 1FN interactions and dependent endothelial cell functions. Here, -defensins were studied in hypoxia-induced proliferative retinopathy. In vitro, -defensins specifically inhibited 5 1-integrindependent migration of bovine retinal endothelial cells (BRECs) to FN, attenuated the VEGF-stimulated increase in endothelial permeability, and blocked BREC proliferation and capillary sprout formation in 3-dimensional fibrin-matrices. An up-regulation of 1-integrin and FN was observed in the retinal vessels in the mouse model of hypoxia-induced retinal angiogenesis. Systemic and local administration of -defensins reduced retinal neovascularization by 45% and 60%, respectively, and this effect was comparable to the inhibitory effect of 5 1-blocking antibody. -Defensins were detected in human diabetic retinas associated with normal retinal vessels but were absent from proliferative lesions. Together, these data show that -defensins inhibit pathologic retinal neovascularization in vivo and may provide a clinically efficient strategy against proliferative retinopathies.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Xu, Y.-s. Wang, W.-b. Pan, B. Xiao, Y.-j. Wen, X.-c. Chen, L.-j. Chen, H.-x. Deng, J. You, B. Kan, et al.
Human {alpha}-defensin-1 inhibits growth of human lung adenocarcinoma xenograft in nude mice
Mol. Cancer Ther.,
June 1, 2008;
7(6):
1588 - 1597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Hubert, L. Herman, C. Maillard, J.-H. Caberg, A. Nikkels, G. Pierard, J.-M. Foidart, A. Noel, J. Boniver, and P. Delvenne
Defensins induce the recruitment of dendritic cells in cervical human papillomavirus-associated (pre)neoplastic lesions formed in vitro and transplanted in vivo
FASEB J,
September 1, 2007;
21(11):
2765 - 2775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. V. Orlova, M. Economopoulou, F. Lupu, S. Santoso, and T. Chavakis
Junctional adhesion molecule-C regulates vascular endothelial permeability by modulating VE-cadherin-mediated cell-cell contacts
J. Exp. Med.,
November 27, 2006;
203(12):
2703 - 2714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. Athanasopoulos, M. Economopoulou, V. V. Orlova, A. Sobke, D. Schneider, H. Weber, H. G. Augustin, S. A. Eming, U. Schubert, T. Linn, et al.
The extracellular adherence protein (Eap) of Staphylococcus aureus inhibits wound healing by interfering with host defense and repair mechanisms
Blood,
April 1, 2006;
107(7):
2720 - 2727.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |